GENE News $GENE Wafergen Bio gets some Gene Te
Post# of 132
Posted On: 02/13/2015 10:42:17 PM
GENE News $GENE
Wafergen Bio gets some Gene Tech love
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 2:47PM CST
GENE: 8.04 (+1.90), SGNL: 3.91 (+2.15), WGBS: 4.40 (+1.02)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 11:45AM CST
CYTK: 7.78 (+1.29), MNOV: 3.62 (-0.56), MX: 7.52 (-7.50), SIEB: 1.71 (-0.24), QKLS: 2.10 (-0.24), YUMA: 1.88 (+0.67), CYBR: 52.52 (+6.83), KN: 18.59 (-3.05), COLM: 51.50 (+7.91), BIOC: 1.41 (+0.22), NBG: 1.61 (+0.18), CECO: 5.34 (-0.92), GENE: 8.04 (+1.90), SGNL: 3.91 (+2.15), IMI: 1.70 (-0.20), RCKY: 18.43 (+4.33), WAC: 20.29 (+2.57), FNJN: 2.77 (-0.36), ZNGA: 2.24 (-0.42), PRAN: 1.09 (-0.55)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
CYTK: 7.78 (+1.29), HK: 2.18 (-0.02), CYBR: 52.52 (+6.83), FXEN: 1.99 (+0.10), NBG: 1.61 (+0.18), MBT: 10.36 (+0.62), SDRL: 12.32 (-0.70), MTSN: 4.04 (+0.19), BLDP: 2.66 (-0.26), GDP: 3.58 (+0.29), REXX: 5.08 (+0.13), DNR: 8.66 (+0.39), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), SD: 2.09 (+0.14), MX: 7.52 (-7.50), KN: 18.59 (-3.05), GENE: 8.04 (+1.90), VDSI: 27.86 (+2.69), IDRA: 4.10 (-0.14), SFY: 2.91 (+0.26), ARIA: 7.35 (+0.45), FSL: 37.53 (+2.83), PRAN: 1.09 (-0.55), OAS: 16.84 (-0.03)
Genetic Tech quadruples in 2 weeks on breast cancer test ramp up
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 9:11AM CST
GENE: 8.04 (+1.90)
Short Sellers Eye Genetic Tech
Interactive Brokers - Seeking Alpha - Tue Feb 10, 1:58PM CST
Following the recent increase in its share price, Genetic Tech Ltd. (NASDAQ: GENE ) was a highly sought-after short-borrow request. Limited availability pushed the cost to borrow up substantially while demand remains strong. Shares in GENE spiked...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), SHAK: 40.69 (+0.04), DDD: 32.81 (+0.40), BBEP: 7.85 (+0.32), SN: 15.21 (-0.12), YOD: 2.22 (+0.04), MNKD: 7.00 (+0.02), MCP: 0.97 (+0.04), GENE: 8.04 (+1.90), BTU: 7.65 (+0.46), IMRS: 1.04 (-0.03), PSTR: 4.63 (+0.14), LINE: 12.94 (+0.40)
Genetic Tech continues surge, shares up 23%
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:22AM CST
GENE: 8.04 (+1.90)
Tech Stocks in Focus: From IPOs to Breaking News, Here's What's Happening
PR Newswire - Mon Feb 02, 8:44AM CST
U.S. tech stocks have begun to gain more attention as the media targets 2015's IPO season. Earnings reports and new developments have seemed to helped fuel this frenzy of buzz but not all attention was sprung from good news. Companies like Alibaba for example, fell short of targets leaving investors disappointed and share prices in the lurch. However, companies like cloud storage company, Box (NYSE:BOX), Facebook (NASDAQ:FB), World Moto Inc (OTCQB:FARE), Blue Calypso, Inc (OTCQB:BCYP), and Genetic Technologies Ltd (NASDAQ:GENE) have all made the news during the early parts of 2015
GENE: 8.04 (+1.90), BOX: 20.18 (+0.01), FB: 75.74 (-0.49)
Genetic Technologies up on breast cancer test uptake
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 9:23AM CST
GENE: 8.04 (+1.90)
Genetic Technologies Announces up to 6 New Breast Centres to Begin Offering BREVAGenplus(R)
Marketwired - Thu Jan 29, 4:30AM CST
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"
is pleased to report that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus(R) to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar year 2015. As a result, the Company expects sales growth to accelerate in the second half 2015 and beyond.
GENE: 8.04 (+1.90)
Genetic Technologies Secures A$24 Million Standby Equity Placement Facility
Marketwired - Wed Jan 21, 5:28PM CST
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Genetic Technologies" or the "Company" today announced that it has entered into a A$24 million Standby Equity Placement Facility Agreement (the "Facility" or "Agreement" with the Kentgrove Capital Growth Fund ("Kentgrove Capital", an investment fund managed by Kentgrove Capital Pty Ltd, a Melbourne-based investment and advisory firm, to strengthen the Company's funding position.
GENE: 8.04 (+1.90)
Wafergen Bio gets some Gene Tech love
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 2:47PM CST
GENE: 8.04 (+1.90), SGNL: 3.91 (+2.15), WGBS: 4.40 (+1.02)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 11:45AM CST
CYTK: 7.78 (+1.29), MNOV: 3.62 (-0.56), MX: 7.52 (-7.50), SIEB: 1.71 (-0.24), QKLS: 2.10 (-0.24), YUMA: 1.88 (+0.67), CYBR: 52.52 (+6.83), KN: 18.59 (-3.05), COLM: 51.50 (+7.91), BIOC: 1.41 (+0.22), NBG: 1.61 (+0.18), CECO: 5.34 (-0.92), GENE: 8.04 (+1.90), SGNL: 3.91 (+2.15), IMI: 1.70 (-0.20), RCKY: 18.43 (+4.33), WAC: 20.29 (+2.57), FNJN: 2.77 (-0.36), ZNGA: 2.24 (-0.42), PRAN: 1.09 (-0.55)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
CYTK: 7.78 (+1.29), HK: 2.18 (-0.02), CYBR: 52.52 (+6.83), FXEN: 1.99 (+0.10), NBG: 1.61 (+0.18), MBT: 10.36 (+0.62), SDRL: 12.32 (-0.70), MTSN: 4.04 (+0.19), BLDP: 2.66 (-0.26), GDP: 3.58 (+0.29), REXX: 5.08 (+0.13), DNR: 8.66 (+0.39), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96), SD: 2.09 (+0.14), MX: 7.52 (-7.50), KN: 18.59 (-3.05), GENE: 8.04 (+1.90), VDSI: 27.86 (+2.69), IDRA: 4.10 (-0.14), SFY: 2.91 (+0.26), ARIA: 7.35 (+0.45), FSL: 37.53 (+2.83), PRAN: 1.09 (-0.55), OAS: 16.84 (-0.03)
Genetic Tech quadruples in 2 weeks on breast cancer test ramp up
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 9:11AM CST
GENE: 8.04 (+1.90)
Short Sellers Eye Genetic Tech
Interactive Brokers - Seeking Alpha - Tue Feb 10, 1:58PM CST
Following the recent increase in its share price, Genetic Tech Ltd. (NASDAQ: GENE ) was a highly sought-after short-borrow request. Limited availability pushed the cost to borrow up substantially while demand remains strong. Shares in GENE spiked...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), SHAK: 40.69 (+0.04), DDD: 32.81 (+0.40), BBEP: 7.85 (+0.32), SN: 15.21 (-0.12), YOD: 2.22 (+0.04), MNKD: 7.00 (+0.02), MCP: 0.97 (+0.04), GENE: 8.04 (+1.90), BTU: 7.65 (+0.46), IMRS: 1.04 (-0.03), PSTR: 4.63 (+0.14), LINE: 12.94 (+0.40)
Genetic Tech continues surge, shares up 23%
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 9:22AM CST
GENE: 8.04 (+1.90)
Tech Stocks in Focus: From IPOs to Breaking News, Here's What's Happening
PR Newswire - Mon Feb 02, 8:44AM CST
U.S. tech stocks have begun to gain more attention as the media targets 2015's IPO season. Earnings reports and new developments have seemed to helped fuel this frenzy of buzz but not all attention was sprung from good news. Companies like Alibaba for example, fell short of targets leaving investors disappointed and share prices in the lurch. However, companies like cloud storage company, Box (NYSE:BOX), Facebook (NASDAQ:FB), World Moto Inc (OTCQB:FARE), Blue Calypso, Inc (OTCQB:BCYP), and Genetic Technologies Ltd (NASDAQ:GENE) have all made the news during the early parts of 2015
GENE: 8.04 (+1.90), BOX: 20.18 (+0.01), FB: 75.74 (-0.49)
Genetic Technologies up on breast cancer test uptake
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 9:23AM CST
GENE: 8.04 (+1.90)
Genetic Technologies Announces up to 6 New Breast Centres to Begin Offering BREVAGenplus(R)
Marketwired - Thu Jan 29, 4:30AM CST
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"
is pleased to report that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus(R) to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar year 2015. As a result, the Company expects sales growth to accelerate in the second half 2015 and beyond. GENE: 8.04 (+1.90)
Genetic Technologies Secures A$24 Million Standby Equity Placement Facility
Marketwired - Wed Jan 21, 5:28PM CST
Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Genetic Technologies" or the "Company"
today announced that it has entered into a A$24 million Standby Equity Placement Facility Agreement (the "Facility" or "Agreement" with the Kentgrove Capital Growth Fund ("Kentgrove Capital", an investment fund managed by Kentgrove Capital Pty Ltd, a Melbourne-based investment and advisory firm, to strengthen the Company's funding position. GENE: 8.04 (+1.90)
(0)
(0)